AMNEAL PHARMACEUTICALS, INC. Current Liabilities
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Current Liabilities of $883.19 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Liabilities, Current $883.19M.
- 2026-03-31: Liabilities, Current $728.05M.
- 2025-12-31: Liabilities, Current $881.63M.
- 2025-09-30: Liabilities, Current $862.11M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $883.19M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $728.05M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $881.63M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $862.11M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $1.11B 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $1.08B 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $1.13B 10-K · filed 2026-02-27 | |
| 2024-09-30 | $1.10B 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.11B 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $834.39M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $846.60M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $760.60M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $777.35M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $703.71M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $752.80M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $818.00M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $993.06M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $602.04M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $677.24M 10-K · filed 2023-03-03 | |
| 2021-09-30 | $667.34M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $672.86M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $636.78M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $676.90M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $667.89M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $655.02M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $965.07M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $550.41M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $534.91M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $546.16M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $599.53M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $553.85M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $749.27M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $669.74M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $296.88M 10-K · filed 2019-03-01 | $0.00 10-K · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |